Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

combination therapy

  • You have access
    Investigation into Enhancing Capecitabine Efficacy in Colorectal Cancer by Inhibiting Focal Adhesion Kinase Signaling
    JAE JUN SIM, MIN HEE PARK, JEONG-HEUM BAEK, HAEJUN LEE, KEUN-YEONG JEONG and HWAN MOOK KIM
    Anticancer Research August 2018, 38 (8) 4667-4676; DOI: https://doi.org/10.21873/anticanres.12772
  • You have access
    Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer
    KOICHI SAKAGUCHI, KATSUHIKO NAKATSUKASA, HIROSHI KOYAMA, MAKOTO KATO, AKIRA SAKUYAMA, TAKAYUKI MATSUDA, NOBUYUKI TSUNODA, IKUYA FUJIWARA, MASAHIDE YAMAGUCHI, HIROKI TANAKA, KAZUYOSHI ONISHI, MIE ONISHI, YUJI YOSHINO, TAKASHI KIKUCHI and TETSUYA TAGUCHI
    Anticancer Research July 2018, 38 (7) 4073-4081; DOI: https://doi.org/10.21873/anticanres.12697
  • You have access
    Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells
    NAYOUNG KIM, MIN-JUNG KANG, SANG HYUB LEE, JUN HYUK SON, JI EUN LEE, WOO HYUN PAIK, JI KON RYU and YONG-TAE KIM
    Anticancer Research June 2018, 38 (6) 3527-3533; DOI: https://doi.org/10.21873/anticanres.12624
  • You have access
    In Vitro Elucidation of Drug Combination Synergy in Treatment of Pancreatic Ductal Adenocarcinoma
    KEVIN T. BUSH, AMELIE BOICHARD and IGOR F. TSIGELNY
    Anticancer Research April 2018, 38 (4) 1967-1977;
  • You have access
    Combination Treatment of Polo-Like Kinase 1 and Tankyrase-1 Inhibitors Enhances Anticancer Effect in Triple-negative Breast Cancer Cells
    GEUN-HYOUNG HA, DONG-YOUNG KIM, EUN-KYOUNG BREUER and CHUNG KWON KIM
    Anticancer Research March 2018, 38 (3) 1303-1310;
  • You have access
    Antimetastatic Efficacy of the Combination of Caffeine and Valproic Acid on an Orthotopic Human Osteosarcoma Cell Line Model in Nude Mice
    KENTARO IGARASHI, KEI KAWAGUCHI, TASUKU KIYUNA, TAKASHI MURAKAMI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Anticancer Research March 2017, 37 (3) 1005-1011;
  • You have access
    Second-line Erlotinib or Intermittent Erlotinib plus Docetaxel in Male Ex-smokers with Squamous NSCLC: The TALISMAN Randomized Trial
    CESARE GRIDELLI, ANTONIO CHELLA, GIUSEPPE VALMADRE, GIACOMO ALLEGRINI, MATTEO BRIGHENTI, PAOLO BIDOLI, ANTONIO ROSSI, PAOLO MAIONE, MARIA RITA MIGLIORINO, SERENA RICCIARDI and FILIPPO DE MARINIS
    Anticancer Research December 2016, 36 (12) 6535-6540;
  • You have access
    The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells
    KAROLINA LAPINSKA, GENEVIEVE HOUSMAN, SHANNON BYLER, SARAH HEERBOTH, AMBER WILLBANKS, ANUJA OZA and SIBAJI SARKAR
    Anticancer Research November 2016, 36 (11) 5731-5742;
  • You have access
    TAS-102 an Emerging Oral Fluoropyrimidine
    JIEZHONG CHEN, MEI HAN and MUHAMMAD WASIF SAIF
    Anticancer Research January 2016, 36 (1) 21-26;
  • You have access
    Celecoxib and LLW-3-6 Reduce Survival of Human Glioma Cells Independently and Synergistically with Sulfasalazine
    TOKUNBO YEROKUN and LEYTE L. WINFIELD
    Anticancer Research December 2015, 35 (12) 6419-6424;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire